The NHMRC has awarded IMB's Professor David Fairlie $557,000 over three years to develop new drug treatments for malaria, a disease that kills an estimated 584,000 people worldwide each year.

Professor Matthew Cooper and Dr Mark Butler have received the prestigious JA Medal for a review the pair authored titled ‘Antibiotics in the Clinical Pipeline in 2011’.

UQ’s Institute for Molecular Bioscience (IMB) and Australian Institute for Bioengineering and Nanotechnology (AIBN) are inviting interested locals to join them for a public author event from 5.30pm on Wednesday 1 April to celebrate Penguin Random House’s upcoming new release.

UQ scientists have brought a retired sex gene in mammals back to life, proving it can still switch on male development in mice despite not having done so for millions of years.

A University of Queensland research team has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research to target brain inflammation in people with Parkinson’s disease.

IMB researchers have found seven peptides (mini-proteins) in spider venom that block the molecular pathway responsible for sending pain signals from nerves to the brain.

Researchers from IMB’s Centre for Rare Diseases Research are calling on Queenslanders to show their support for international Rare Disease Day tomorrow (28 February).

Scientists from Australia and the UK have completed the most comprehensive analysis yet of pancreatic cancer, in a study that could improve future treatments.

Scientists in Brisbane and Ireland have developed a small molecule that blocks a key driver of inflammatory diseases – a finding that could inspire new treatments for arthritis, multiple sclerosis and a family of rare autoinflammatory diseases.